RxDoctor Payments Data

Jennifer Counceller, NP

Family · Connersville, INNPI 1750752853

Payments from drug & device makers

$620in general payments, 2019–2025

Across 34 payments — averaging $18.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$172
  • Novo Nordisk$67
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$61
  • Pfizer$58
  • Otsuka America Pharmaceutical, Inc.$48
  • Lilly USA, LLC$47
  • plus $167 from 8 others

What the payments were for

  • Food & beverage$620100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$620 in reported general payments places this provider in the 55th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$63,466
Medicare patients
238
Services billed
1,675

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide118$122,214
MounjaroTirzepatide107$114,415
Trelegy ElliptaFluticasone/Umeclidin/Vilanter73$53,602
EliquisApixaban52$38,373
TrulicityDulaglutide33$34,785
JardianceEmpagliflozin36$26,251
LinzessLinaclotide20$19,888
EntrestoSacubitril/Valsartan14$13,239
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen288$5,067
Advair HfaFluticasone Propion/Salmeterol15$3,992
ElmironPentosan Polysulfate Sodium12$3,987
Albuterol Sulfate HfaAlbuterol Sulfate183$3,929
Duloxetine Hcl167$3,721
Ventolin HfaAlbuterol Sulfate44$3,462
Pantoprazole Sodium340$3,455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$47$149,199140 claims
Novo NordiskOzempic$67$122,214118 claims
GSKTrelegy Ellipta$15$53,60273 claims
PfizerEliquis$58$38,37352 claims
AbbVieLinzess$172$19,88820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,392 family providers in Indiana.

Other family in Connersville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →